Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Ziming Zheng; Yumei Huang; Jijuan Zhang; Jinchi Xie; An Pan; Yunfei Liao; Yu Zhang;

Different measures of sodium intake and the risk of metabolic dysfunction-associated steatotic liver disease: Evidence from the UK Biobank Shiqi Zhu; Lihe Liu; Yiping Shen; Rui Li; Jiaxi Lin; Lu Liu; Xiaolin Liu; Hongpeng Sun; Jinzhou Zhu;

Is FIB-4 the right tool for screening for liver fibrosis? Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;